Republican Sen. Josh Hawley’s quest to legitimize a junk science report undermining the safety of a widely used abortion pill was fully realized this week. “As with all drugs, FDA continues to ...

The US Food and Drug Administration held off a legal challenge from a coalition of blue states over the abortion pill, ...

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

This article was originally featured on The Conversation. For many people, accessing abortion care can be a major challenge. Abortion services are usually only available in certain clinics with ...

Three RU-486 Mifeprex (mifepristone) abortion pills are held in a hand in a picture taken on ...More December 1, 2000. The RU-486 pill was approved in September 2000.

Research increasingly indicates that people are interested in OTC access to abortion pills. In a 2017 survey we conducted of over 7,000 U.S. women ages 18-49 about their interest in obtaining ...

@HawleyMO asks RFK Jr. if he will study limiting the abortion pill following a report that 11% of women experience adverse effects. "I've asked Marty Makary, who's the director of FDA, to do a ...

By questioning the FDA's authority to regulate an abortion drug, ... Will ruling on abortion pill mifepristone access limit FDA's authority on all ... scientific review of efficacy and safety.

Upadhyay has recently submitted a study for peer review comparing the cost of medication abortion obtained through virtual and in-person clinics, and she says the costs are much lower in the former.

Food and Drug Administration Commissioner Martin Makary confirmed in a Monday letter to the Missouri senator that the agency will conduct a safety review of the abortion pill mifepristone.Makary ...

Republican Sen. Josh Hawley’s quest to legitimize a junk science report undermining the safety of a widely used abortion pill was fully realized this week. Food and Drug Administration Commissioner ...